134 related articles for article (PubMed ID: 11605074)
1. Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer.
Kuczyk MA; Bokemeyer C; Hartmann J; Schubach J; Walter C; Machtens S; Knuchel R; Kollmannsberger C; Jonas U; Serth J
Oncol Rep; 2001; 8(6):1401-7. PubMed ID: 11605074
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancer.
Kuczyk MA; Machtens S; Bokemeyer C; Hradil K; Macheel I; Jetscho V; Hartmann J; Thon WF; Jonas U; Serth J
Oncol Rep; 1999; 6(3):687-93. PubMed ID: 10203616
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
Kuczyk M; Machtens S; Hradil K; Schubach J; Christian W; Knüchel R; Hartmann J; Bokemeyer C; Jonas U; Serth J
Br J Cancer; 1999 Nov; 81(6):1052-8. PubMed ID: 10576664
[TBL] [Abstract][Full Text] [Related]
4. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
Tsihlias J; Kapusta LR; DeBoer G; Morava-Protzner I; Zbieranowski I; Bhattacharya N; Catzavelos GC; Klotz LH; Slingerland JM
Cancer Res; 1998 Feb; 58(3):542-8. PubMed ID: 9458103
[TBL] [Abstract][Full Text] [Related]
5. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?
Schwandner O; Bruch HP; Broll R
Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448
[TBL] [Abstract][Full Text] [Related]
6. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma.
Cote RJ; Shi Y; Groshen S; Feng AC; Cordon-Cardo C; Skinner D; Lieskovosky G
J Natl Cancer Inst; 1998 Jun; 90(12):916-20. PubMed ID: 9637141
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
8. p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb.
Nita ME; Nagawa H; Tominaga O; Tsuno N; Hatano K; Kitayama J; Tsuruo T; Domene CE; Muto T
Ann Surg Oncol; 1999; 6(5):481-8. PubMed ID: 10458687
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy.
Kuczyk MA; Serth J; Bokemeyer C; Machtens S; Minssen A; Bathke W; Hartmann J; Jonas U
Eur J Cancer; 1998 Apr; 34(5):679-86. PubMed ID: 9713274
[TBL] [Abstract][Full Text] [Related]
10. Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
Yang RM; Naitoh J; Murphy M; Wang HJ; Phillipson J; deKernion JB; Loda M; Reiter RE
J Urol; 1998 Mar; 159(3):941-5. PubMed ID: 9474188
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
[TBL] [Abstract][Full Text] [Related]
12. Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers.
Migaldi M; Sgambato A; Garagnani L; Ardito R; Ferrari P; De Gaetani C; Cittadini A; Trentini GP
Clin Cancer Res; 2000 Aug; 6(8):3131-8. PubMed ID: 10955794
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
14. Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers.
Sgambato A; Migaldi M; Faraglia B; Garagnani L; Romano G; De Gaetani C; Ferrari P; Capelli G; Trentini GP; Cittadini A
Cancer Res; 1999 Jul; 59(13):3245-50. PubMed ID: 10397272
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
17. Independence of the prognostic value of tumor suppressor protein expression in ovarian adenocarcinomas: A multivariate analysis of expression of p53, retinoblastoma, and related proteins.
Tachibana M; Watanabe J; Matsushima Y; Nishida K; Kobayashi Y; Fujimura M; Shiromizu K
Int J Gynecol Cancer; 2003; 13(5):598-606. PubMed ID: 14675342
[TBL] [Abstract][Full Text] [Related]
18. Reduction of PTEN and p27kip1 expression correlates with tumor grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies.
Dreher T; Zentgraf H; Abel U; Kappeler A; Michel MS; Bleyl U; Grobholz R
Virchows Arch; 2004 Jun; 444(6):509-17. PubMed ID: 15118854
[TBL] [Abstract][Full Text] [Related]
19. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features.
Machtens S; Serth J; Bokemeyer C; Bathke W; Minssen A; Kollmannsberger C; Hartmann J; Knüchel R; Kondo M; Jonas U; Kuczyk M
Int J Cancer; 2001 Sep; 95(5):337-42. PubMed ID: 11494236
[TBL] [Abstract][Full Text] [Related]
20. The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy.
Cheng L; Lloyd RV; Weaver AL; Pisansky TM; Cheville JC; Ramnani DM; Leibovich BC; Blute ML; Zincke H; Bostwick DG
Clin Cancer Res; 2000 May; 6(5):1896-9. PubMed ID: 10815913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]